United States of America v. Takeda Pharmaceuticals America, Inc.

District Court, N.D. Illinois·Decided May 9, 2023·No. 1:14-cv-09412·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

UNITED STATES, ex rel. RONALD J. STRECK,

Plaintiff, Case No. 14 C 9412

v. Judge Harry D. Leinenweber TAKEDA PHARMACEUTICALS AMERICA, INC., et al.,

Defendants.

MEMORANDUM OPINION AND ORDER

I. BACKGROUND

After a jury verdict, the Court entered judgment in favor of the Relator Ronald J. Streck (“Relator”) against Defendant Eli Lilly and Company (“Lilly”) on qui tam actions under the federal False Claims Act (the “FCA”) and various state false claims acts (Dkt. No. 486). Relator has now filed a post-trial Motion under Federal Rule of Civil Procedure 59 to Amend Judgment (Dkt. No. 495). Relator seeks trebled damages, prejudgment interest on actual damages, post-judgement interest, and maximum civil penalties. For the reasons stated herein, the Court grants in part and denies in part the Motion. II. DISCUSSION A. Trebled Damages Under Section 3729 of the FCA, a defendant is liable for “3

times the amount of damages which the Government sustains because of the act of [the defendant].” 31 U.S.C. § 3729(a). Defendants do not dispute that the relevant state statutes call for the same. The jury determined the actual damages to the federal and state governments to be $61,229,217. (Dkt. No. 486.) This figure tripled amounts to $183,687,651. Lilly owes trebled damages totaling $183,687,651. B. Prejudgment Interest Under the FCA Relator asks this Court to impose prejudgment interest on pre-trebled damages. While the Seventh Circuit has not yet provided firm guidance on the availability of prejudgment interest, this Court is persuaded by other circuits that have expressly disallowed it. See e.g., United States v. McLeod, 721 F.2d 282, 286 (9th Cir. 1983); Peterson v. Weinberger, 508 F.2d 45, 55 (5th Cir. 1975);

United States v. Foster Wheeler Corp., 447 F.2d 100, 102 (2d Cir. 1971). Relator cites one case for its position, U.S. v. Coop. Grain & Supply Co., 476 F.2d 47, 62 (8th Cir. 1973). Generally, a remedy is not foreclosed simply because the statute does not mandate it. See Rodgers v. U.S., 332 U.S. 371 (1947); U.S. v. Texas, 507 U.S. 529, 535 (1993); W. Virginia v. U.S., 479 U.S. 305, 308 (1987); Gorenstein Enterprises, Inc. v. Quality Care-USA, Inc., 874 F.2d 431, 436 (7th Cir. 1989). Relator relies heavily on Gornstein, a 1989 case in which the Seventh Circuit asserted a presumption of prejudgment interest to victims

of federal violations. 874 F.2d 436. Since then, the Supreme Court has remarked on the lack of prejudgment interest in the FCA qui tam actions. See Cook Cnty., Ill. v. U.S. ex rel. Chandler, 538 U.S. 120, 131 (2003). This Court finds any presumption of prejudgment interest eclipsed by the FCA itself. The lack of a prejudgment interest provision in Congress’s scheme for relator recoveries under Section 3729 of the FCA expressly differs from other portions of the statute. In the provision of the FCA dealing with retaliation against whistleblowers – not at issue here – Congress specifically authorized it. 31 U.S.C. § 3730(h) (“Relief . . . shall include . . . 2 times the amount of back pay [and] interest on the back pay.

. . .”). The history of the FCA also renders the scarcity of support for Relator’s position unsurprising. Congress was aware of courts’ interpretations when it amended the statute in both 1986 and 2009 but never added prejudgment interest to the text. Such inaction suggests that Congress intended to exclude this remedy. See Cannon v. University of Chicago, 441 U.S. 677, 703 (1979); Monessen Sw. Ry. Co. v. Morgan, 486 U.S. 330, 338 (1988). The Supreme Court has suggested that an amendment Congress did make, the trebling of damages, renders prejudgment interest redundant at best. See Chandler, 538 U.S. at 131-33. In 1986, Congress raised the ceiling on damages recoverable under § 3729(a) from double to treble. See id. at 120. While Grain & Supply, 476

F.2d 62, also was published before the amendment, the Eighth Circuit’s reasoning would make little sense afterwards. In Grain & Supply, the 8th Circuit explained that prejudgment interest was important to compensate the plaintiff. Id. The Supreme Court has characterized the trebling of FCA damages as exceeding the bounds of compensation now to serve punitive, rather than merely compensatory, purposes. See Chandler, 538 U.S. at 133; Vermont Agency of Nat. Res. v. U.S. ex rel. Stevens, 529 U.S. 765, 784- 86, (2000) (“[T]he current version of the FCA imposes damages that are essentially punitive in nature.”); see also Universal Health Servs., Inc. v. U.S., 579 U.S. 176, 182 (2016). Indeed, as the Supreme Court explained in Chandler, the FCA’s

trebled damages feature ultimately serves more than one purpose. 538 U.S. at 133. Relator sets forth a reasonable policy argument that the recognition of the time value of money, an economic reality accounted for by prejudgment interest, ensures fair compensation. However, the law instructs otherwise, seemingly in pursuit of a countervailing policy goal. “In qui tam cases the rough difference between double and triple damages may well serve . . . to quicken the self-interest of some private plaintiff who can spot violations and start litigating to compensate the Government, while benefiting himself as well.” Id. at 131. With an aim for speedy litigation, the exclusion of prejudgment interest makes sense. Congress, recognizing the time value of money, would

assume rational relators would push for efficient litigation to obtain the award for themselves, ipso facto the Government, as quickly as possible. For these reasons, the Court declines to award Relator prejudgment interest under the federal FCA. C. Prejudgment Interest Under State FCAs Relator also requests the Court award prejudgment interest on the damages amount under the 27 state FCAs and the District of Columbia FCA (“state FCAs” or “state statutes”). Lilly concedes that claims under Texas and Louisiana statutes – namely, the Texas Medicaid Fraud Prevention Act and the Louisiana Medical Assistance Programs Integrity Law – are entitled to prejudgment interest. The

parties present partial, opposing arguments for several additional states and the District of Columbia (“states”).

Free access — add to your briefcase to read the full text and ask questions with AI

United States of America v. Takeda Pharmaceuticals America, Inc., (N.D. Ill. 2023).

United States of America v. Takeda Pharmaceuticals America, Inc. (United States of America v. Takeda Pharmaceuticals America, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Rodgers v. United States
332 U.S. 371 (Supreme Court, 1947)
Cannon v. University of Chicago
441 U.S. 677 (Supreme Court, 1979)
West Virginia v. United States
479 U.S. 305 (Supreme Court, 1987)
Monessen Southwestern Railway Co. v. Morgan
486 U.S. 330 (Supreme Court, 1988)
United States v. Texas
507 U.S. 529 (Supreme Court, 1993)
New York v. Amgen Inc.
652 F.3d 103 (First Circuit, 2011)
United States v. Foster Wheeler Corporation
447 F.2d 100 (Second Circuit, 1971)
United States Ex Rel. Tyson v. Amerigroup Illinois, Inc.
488 F. Supp. 2d 719 (N.D. Illinois, 2007)
Peterson v. Weinberger
508 F.2d 45 (Fifth Circuit, 1975)